These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24279589)

  • 21. Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus.
    Li Q; Sun X; Li Z; Liu Y; Vavricka CJ; Qi J; Gao GF
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18897-902. PubMed ID: 23012237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.
    Zanin M; Duan S; Wong SS; Kumar G; Baviskar P; Collin E; Russell C; Barman S; Hause B; Webby R
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MD simulation of the interaction between sialoglycans and the second sialic acid binding site of influenza A virus N1 neuraminidase.
    Elli S; Gambacorta N; Rudd TR; Matrosovich M; Guerrini M
    Biochem J; 2021 Jan; 478(2):423-441. PubMed ID: 33410905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.
    Crennell SJ; Garman EF; Laver WG; Vimr ER; Taylor GL
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9852-6. PubMed ID: 8234325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.
    Dai M; Guo H; Dortmans JC; Dekkers J; Nordholm J; Daniels R; van Kuppeveld FJ; de Vries E; de Haan CA
    J Virol; 2016 Oct; 90(20):9457-70. PubMed ID: 27512075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for a class of nanomolar influenza A neuraminidase inhibitors.
    Kerry PS; Mohan S; Russell RJ; Bance N; Niikura M; Pinto BM
    Sci Rep; 2013 Oct; 3():2871. PubMed ID: 24129600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
    Hsu KC; Hung HC; HuangFu WC; Sung TY; Eight Lin T; Fang MY; Chen IJ; Pathak N; Hsu JT; Yang JM
    Sci Rep; 2017 Sep; 7(1):12336. PubMed ID: 28951584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza A virus N5 neuraminidase has an extended 150-cavity.
    Wang M; Qi J; Liu Y; Vavricka CJ; Wu Y; Li Q; Gao GF
    J Virol; 2011 Aug; 85(16):8431-5. PubMed ID: 21653672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.
    Reid AH; Fanning TG; Janczewski TA; Taubenberger JK
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6785-90. PubMed ID: 10823895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycan binding and specificity of viral influenza neuraminidases by classical molecular dynamics and replica exchange molecular dynamics simulations.
    Phanich J; Threeracheep S; Kungwan N; Rungrotmongkol T; Hannongbua S
    J Biomol Struct Dyn; 2019 Aug; 37(13):3354-3365. PubMed ID: 30126341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
    Du W; Guo H; Nijman VS; Doedt J; van der Vries E; van der Lee J; Li Z; Boons GJ; van Kuppeveld FJM; de Vries E; Matrosovich M; de Haan CAM
    PLoS Pathog; 2019 Jun; 15(6):e1007860. PubMed ID: 31181126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.
    Li Q; Qi J; Wu Y; Kiyota H; Tanaka K; Suhara Y; Ohrui H; Suzuki Y; Vavricka CJ; Gao GF
    J Virol; 2013 Sep; 87(18):10016-24. PubMed ID: 23824808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
    Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
    Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.
    Yang Z; Yang G; Zhou L
    J Comput Aided Mol Des; 2013 Nov; 27(11):935-50. PubMed ID: 24218291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses.
    Uhlendorff J; Matrosovich T; Klenk HD; Matrosovich M
    Arch Virol; 2009; 154(6):945-57. PubMed ID: 19458903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
    Prachanronarong KL; Özen A; Thayer KM; Yilmaz LS; Zeldovich KB; Bolon DN; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Kurt-Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2016 Dec; 12(12):6098-6108. PubMed ID: 27951676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.